Pharmacokinetics of LCQ908 in Patients With Renal Impairment

Clinical trial NCT01558323 · COMPLETED

Trial details

NCT number: NCT01558323
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Impairment

Start date: 2012-05-01
Primary completion: 2013-03-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.